Evidence map›Paper›PMID 39300408›Full record

ArticleBMC neurology2024

Febrile neutropenia induced by adjuvant radiotherapy for a patient with breast cancer accompanied with reversible splenial lesion syndrome (RESLES, TypeI): a case report.

Xiao Qi, Dandan Zou, Miao Zhang, Huaqing Wang

Abstract readCase Reports
In one paragraph

Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiao QiDepartment of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin, China.
Dandan ZouDepartment of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin, China.
Miao ZhangDepartment of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin, China. zhangmiao810208@126.com.
Huaqing WangDepartment of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin, China. huaqingw@163.com.

Funding

National Natural Science Foundation of China 82070206Tianjin Health Research Project TJWJ2023MS013Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-053B
6 · The paper itself

Abstract

backgroundReversible splenial lesion syndrome (RESLES) is known as a neuro-imaging syndrome with recurrent but reversible lesion of the corpus callosum, characterized by nonspecific but usually mild encephalopathies and specific imaging manifestations.There are few published reports in the field of oncology. CASE PRESENTATION: A 33-year-old female with right breast cancer and with no particular family history was admitted to hospital with high fever and severe headache, after receiving adjuvant radiotherapy. Blood routine test upon admission suggested neutropenia, considering myelosuppression associated with radiotherapy. There were no definite findings of common pathogenic microorganism, and no imaging indication of certain infectious sites other than a likely reversible corpus callosum syndrome suggested by brain MRI, which was relieved after systemic antibiotic therapy and granulocyte colony-stimulating factor injection.

conclusionsReversible splenial lesion syndrome is a kind of clinical-imaging syndrome with multiple clinical manifestations and etiologies. This breast cancer patient after postoperative adjuvant radiotherapy develops a complication of RESLES that rings an alarm bell to the oncologists not to easily recognize the corpus callosum lesion as infarction or metastasis. Meanwhile, the potential pathogenic mechanisms need to be explored further.

Indexed as

Breast NeoplasmsCorpus CallosumAdultFebrile NeutropeniaFemaleHumansMagnetic Resonance ImagingRadiotherapy, AdjuvantBreast cancerFebrile neutropeniaInfectionRadiotherapyReversible corpus callosum syndrome

Identifiers

PMID39300408
PMCPMC11411757

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.